At a glance
ClinicalIndex Comparison RecordPhase 4Completed· 1,817 enrolled
Drug / intervention
Xuebijing Injection +1 moredrug
Likely dose
Xuebijing Injection 100mlfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
The Efficacy of Xuebijing Injection in Adult Patients With Sepsis
In Brief
A Phase 4 clinical trial evaluating Xuebijing Injection and normal saline for Sepsis. Completed, enrolled 1,817 participants across 1 site.
Detailed Summary
The Efficacy of Xuebijing Injection in Adult Patients with Sepsis
Study Details
Timeline
Phase 4CompletedFinished
201820192020202120222023202420252026
First PostedAug 2017
Enrollment StartOct 2017
Primary CompletionJul 2019
Study CompletionJan 2020
TodayJul 2026
First PostedAug 3, 2017
Enrollment StartOct 20, 2017
Primary CompletionJul 28, 2019
Study CompletionJan 8, 2020
TodayJul 2, 2026
Enrollment to primary: 1.8 yearsPosted 8.9 years ago
Interventions
Xuebijing Injectiondrug
100ml Xuebijing Injection every 12 hours for 5 days
normal salinedrug
200ml normal saline every 12 hours for 5 days